86 related articles for article (PubMed ID: 17343337)
1. Sialylation and fucosylation of cancer-associated prostate specific antigen.
Kosanović MM; Janković MM
J BUON; 2005; 10(2):247-50. PubMed ID: 17343337
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.
Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M
Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns.
Janković MM; Kosanović MM
Clin Biochem; 2005 Jan; 38(1):58-65. PubMed ID: 15607318
[TBL] [Abstract][Full Text] [Related]
4. Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer.
Llop E; Peracaula R
Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
[TBL] [Abstract][Full Text] [Related]
5. Improved cancer specificity in PSA assay using Aleuria aurantia lectin coated Eu-nanoparticles for detection.
Kekki H; Peltola M; van Vliet S; Bangma C; van Kooyk Y; Pettersson K
Clin Biochem; 2017 Jan; 50(1-2):54-61. PubMed ID: 27818346
[TBL] [Abstract][Full Text] [Related]
6. Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer.
Barrabés S; Llop E; Ferrer-Batallé M; Ramírez M; Aleixandre RN; Perry AS; de Llorens R; Peracaula R
Clin Chim Acta; 2017 Jul; 470():97-102. PubMed ID: 28495148
[TBL] [Abstract][Full Text] [Related]
7. Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes.
Llop E; Ferrer-Batallé M; Barrabés S; Guerrero PE; Ramírez M; Saldova R; Rudd PM; Aleixandre RN; Comet J; de Llorens R; Peracaula R
Theranostics; 2016; 6(8):1190-204. PubMed ID: 27279911
[TBL] [Abstract][Full Text] [Related]
8. Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7.
Shori DK; Genter T; Hansen J; Koch C; Wyatt H; Kariyawasam HH; Knight RA; Hodson ME; Kalogeridis A; Tsanakas I
Pflugers Arch; 2001; 443 Suppl 1():S55-61. PubMed ID: 11845304
[TBL] [Abstract][Full Text] [Related]
9. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
Tabarés G; Radcliffe CM; Barrabés S; Ramírez M; Aleixandre RN; Hoesel W; Dwek RA; Rudd PM; Peracaula R; de Llorens R
Glycobiology; 2006 Feb; 16(2):132-45. PubMed ID: 16177264
[TBL] [Abstract][Full Text] [Related]
10. Fucose and sialic acid expressions in human seminal fibronectin and α{1} -acid glycoprotein associated with leukocytospermia of infertile men.
Kratz EM; Faundez R; Katnik-Prastowska I
Dis Markers; 2011; 31(5):317-25. PubMed ID: 22048274
[TBL] [Abstract][Full Text] [Related]
11. Relative sialylation and fucosylation of synovial and plasma fibronectins in relation to the progression and activity of rheumatoid arthritis.
Przybysz M; Maszczak D; Borysewicz K; Szechiński J; Katnik-Prastowska I
Glycoconj J; 2007 Dec; 24(9):543-50. PubMed ID: 17610063
[TBL] [Abstract][Full Text] [Related]
12. Aberrant sialylation of a prostate-specific antigen: Electrochemical label-free glycoprofiling in prostate cancer serum samples.
Pihikova D; Kasak P; Kubanikova P; Sokol R; Tkac J
Anal Chim Acta; 2016 Aug; 934():72-9. PubMed ID: 27506346
[TBL] [Abstract][Full Text] [Related]
13. Quantitative lectin-histochemical and immunohistochemical studies on the occurrence of alpha(2,3)- and alpha(2,6)-linked sialic acid residues in colorectal carcinomas. Relation to clinicopathologic features.
Vierbuchen MJ; Fruechtnicht W; Brackrock S; Krause KT; Zienkiewicz TJ
Cancer; 1995 Sep; 76(5):727-35. PubMed ID: 8625173
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
Becker C; Piironen T; Pettersson K; Björk T; Wojno KJ; Oesterling JE; Lilja H
J Urol; 2000 Jan; 163(1):311-6. PubMed ID: 10604382
[TBL] [Abstract][Full Text] [Related]
15. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract][Full Text] [Related]
16. alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer.
Fukushima K; Satoh T; Baba S; Yamashita K
Glycobiology; 2010 Jan; 20(4):452-60. PubMed ID: 20008118
[TBL] [Abstract][Full Text] [Related]
17. Label-free chronopotentiometric glycoprofiling of prostate specific antigen using sialic acid recognizing lectins.
Belicky S; Černocká H; Bertok T; Holazova A; Réblová K; Paleček E; Tkac J; Ostatná V
Bioelectrochemistry; 2017 Oct; 117():89-94. PubMed ID: 28651174
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of alpha1-acid glycoprotein and fucosylation in hepatitis B patients provides an insight into pathogenesis.
Mondal G; Chatterjee U; Das HR; Chatterjee BP
Glycoconj J; 2009 Dec; 26(9):1225-34. PubMed ID: 19459043
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase-2 and prostate-specific antigen in localized and metastatic prostate cancer.
Kanoh Y; Akahoshi T; Ohara T; Ohtani N; Mashiko T; Ohtani S; Egawa S; Baba S
Anticancer Res; 2002; 22(3):1813-7. PubMed ID: 12168874
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum IgG oligosaccharide chains with prostate cancer progression.
Kanoh Y; Mashiko T; Danbara M; Takayama Y; Ohtani S; Egawa S; Baba S; Akahoshi T
Anticancer Res; 2004; 24(5B):3135-9. PubMed ID: 15510601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
